Back to mobile site

Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 2c

February 15, 2022 4:10 PM EST

Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.43), $0.02 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $37.9 million versus the consensus estimate of $36.7 million.

For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings